Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,867 | 14,716 | 11,433 | 8,906 | 3,816 |
| Marketable Securities | N/A | 3,593 | 5,933 | 550 | 25,264 |
| TOTAL | $24,420 | $19,579 | $17,656 | $9,799 | $29,505 |
| Non-Current Assets | |||||
| PPE Net | 10 | 20 | 25 | 38 | 52 |
| Investments And Advances | 0 | 0 | 0 | 0 | 539 |
| Other Non-Current Assets | 81 | 176 | 63 | 65 | 60 |
| TOTAL | $91 | $196 | $88 | $103 | $651 |
| Total Assets | $24,511 | $19,775 | $17,744 | $9,902 | $30,156 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,270 | 1,304 | 1,115 | 916 | 549 |
| Accrued Expenses | 919 | 1,232 | 1,516 | 2,362 | 2,665 |
| Other current liabilities | 224 | 316 | 350 | 222 | 295 |
| TOTAL | $2,419 | $2,862 | $2,994 | $3,513 | $3,521 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $6 | $16 | $29 | $42 |
| Total Liabilities | $2,419 | $2,868 | $3,010 | $3,542 | $3,563 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,704 | 49,763 | 48,473 | 34,732 | 22,704 |
| Common Shares | 62 | 50 | 40 | 26 | 23 |
| Retained earnings | -150,238 | -130,072 | -110,011 | -98,438 | -73,565 |
| Other shareholders' equity | -101 | -6,102 | -117 | -353 | -879 |
| TOTAL | $22,092 | $16,907 | $14,734 | $6,360 | $26,593 |
| Total Liabilities And Equity | $24,511 | $19,775 | $17,744 | $9,902 | $30,156 |